Coronary collateral growth by external counterpulsation: a randomised controlled trial.

Détails

ID Serval
serval:BIB_C28DFA5BD974
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Coronary collateral growth by external counterpulsation: a randomised controlled trial.
Périodique
Heart (British Cardiac Society)
Auteur⸱e⸱s
Gloekler S., Meier P., de Marchi S.F., Rutz T., Traupe T., Rimoldi S.F., Wustmann K., Steck H., Cook S., Vogel R., Togni M., Seiler C.
ISSN
1468-201X (Electronic)
ISSN-L
1355-6037
Statut éditorial
Publié
Date de publication
02/2010
Peer-reviewed
Oui
Volume
96
Numéro
3
Pages
202-207
Langue
anglais
Notes
Publication types: Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
The efficacy of external counterpulsation (ECP) on coronary collateral growth has not been investigated in a randomised controlled study. Objective To test the hypothesis that ECP augments collateral function during a 1 min coronary balloon occlusion.
Twenty patients with chronic stable coronary artery disease were studied. Before and after 30 h of randomly allocated ECP (20 90 min sessions over 4 weeks at 300 mm Hg inflation pressure) or sham ECP (same setting at 80 mm Hg inflation pressure), the invasive collateral flow index (CFI, no unit) was obtained in 34 vessels without coronary intervention. CFI was determined by the ratio of mean distal coronary occlusive pressure to mean aortic pressure with central venous pressure subtracted from both. Additionally, coronary collateral conductance (occlusive myocardial blood flow per aorto-coronary pressure drop) was determined by myocardial contrast echocardiography, and brachial artery flow-mediated dilatation was obtained.
CFI changed from 0.125 (0.073; interquartile range) at baseline to 0.174 (0.104) at follow-up in the ECP group (p=0.006), and from 0.129 (0.122) to 0.111 (0.125) in the sham ECP group (p=0.14). Baseline to follow-up change of coronary collateral conductance was from 0.365 (0.268) to 0.568 (0.585) ml/min/100 mm Hg in the ECP group (p=0.072), and from 0.229 (0.212) to 0.305 (0.422) ml/min/100 mm Hg in the sham ECP group (p=0.45). There was a correlation between the flow-mediated dilatation change from baseline to follow-up and the corresponding CFI change (r=0.584, p=0.027).
ECP appears to be effective in promoting coronary collateral growth. The extent of collateral function improvement is related to the amount of improvement in the systemic endothelial function.

Mots-clé
Angina Pectoris/physiopathology, Angina Pectoris/therapy, Balloon Occlusion, Chronic Disease, Collateral Circulation/physiology, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Counterpulsation/methods, Female, Hemodynamics, Humans, Male, Middle Aged
Pubmed
Web of science
Création de la notice
07/08/2017 12:23
Dernière modification de la notice
20/08/2019 16:37
Données d'usage